$220 Million is the total value of PURA VIDA INVESTMENTS, LLC's 77 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -5,400 | -100.0% | -0.09% | – |
CBYL | Exit | CARBYLAN THERAPEUTICS INC | $0 | – | -80,000 | -100.0% | -0.12% | – |
SPNC | Exit | SPECTRANETICS CORPcall | $0 | – | -20,000 | -100.0% | -0.13% | – |
ALIM | Exit | ALIMERA SCIENCES INC | $0 | – | -129,597 | -100.0% | -0.13% | – |
GI | Exit | ENDOCHOICE HLDGS INC | $0 | – | -40,000 | -100.0% | -0.14% | – |
ARAY | Exit | ACCURAY INCcall | $0 | – | -100,000 | -100.0% | -0.28% | – |
TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -82,873 | -100.0% | -0.41% | – |
XENT | Exit | INTERSECT ENT INC | $0 | – | -55,000 | -100.0% | -0.52% | – |
HYH | Exit | HALYARD HEALTH INC | $0 | – | -44,573 | -100.0% | -0.63% | – |
TRXC | Exit | TRANSENTERIX INC | $0 | – | -810,404 | -100.0% | -0.85% | – |
SYK | Exit | STRYKER CORP | $0 | – | -22,500 | -100.0% | -0.88% | – |
QGEN | Exit | QIAGEN NV | $0 | – | -78,668 | -100.0% | -0.92% | – |
AFFX | Exit | AFFYMETRIX INC | $0 | – | -259,309 | -100.0% | -1.10% | – |
RMD | Exit | RESMED INCput | $0 | – | -50,000 | -100.0% | -1.13% | – |
HCA | Exit | HCA HOLDINGS INCput | $0 | – | -45,000 | -100.0% | -1.28% | – |
CAH | Exit | CARDINAL HEALTH INCput | $0 | – | -35,000 | -100.0% | -1.32% | – |
COO | Exit | COOPER COS INC | $0 | – | -25,000 | -100.0% | -1.42% | – |
COO | Exit | COOPER COS INCput | $0 | – | -25,000 | -100.0% | -1.42% | – |
XLI | Exit | SELECT SECTOR SPDR TRput | $0 | – | -65,000 | -100.0% | -1.45% | – |
BAX | Exit | BAXTER INTL INCcall | $0 | – | -100,000 | -100.0% | -1.61% | – |
EW | Exit | EDWARDS LIFESCIENCES CORPcall | $0 | – | -50,000 | -100.0% | -1.67% | – |
LIVN | Exit | LIVANOVA PLC | $0 | – | -67,500 | -100.0% | -1.69% | – |
NUVA | Exit | NUVASIVE INC | $0 | – | -80,000 | -100.0% | -1.83% | – |
BDX | Exit | BECTON DICKINSON & COput | $0 | – | -30,000 | -100.0% | -1.95% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INCput | $0 | – | -56,000 | -100.0% | -2.48% | – |
XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -85,000 | -100.0% | -2.52% | – |
IBB | Exit | ISHARES TRput | $0 | – | -18,000 | -100.0% | -2.57% | – |
BRKR | Exit | BRUKER CORP | $0 | – | -265,000 | -100.0% | -2.72% | – |
TFX | Exit | TELEFLEX INCcall | $0 | – | -50,000 | -100.0% | -2.77% | – |
CI | Exit | CIGNA CORPORATION | $0 | – | -57,500 | -100.0% | -3.55% | – |
AZN | Exit | ASTRAZENECA PLCput | $0 | – | -92,500 | -100.0% | -3.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.